An incident in Madrid has sent shockwaves through Spain’s healthcare system. A woman was unaware for seven years that she had contracted the human papillomavirus, which later developed into cancer and resulted in infertility. This compensation ruling has become one of the most debated topics among the country’s medical community, raising concerns about patient notification standards and the accountability of healthcare institutions.
In January 2015, a woman from Ciempozuelos (Madrid) visited her local health center for a routine Pap smear. Doctors identified a fungal infection but did not inform her about other suspicious cells found in the sample. Several months later, a follow-up examination revealed a high-risk strain of human papillomavirus. Even then, she wasn’t notified of the results or invited for further tests.
The price of silence
Seven years later, when alarming symptoms appeared, the diagnosis was devastating — a 5.5-centimeter malignant tumor on the cervix. A radical surgery at the Infanta Elena hospital resulted in the loss of her ability to have children. She underwent chemotherapy and radiotherapy and faced serious health consequences: long-term anticoagulant use, vascular problems, leg pain, lymphedema and other complications. Ultimately, she was forced to take extended medical leave.
As El Pais notes, the Legal Affairs Commission of Madrid acknowledged that the patient had not received the necessary information about her diagnosis, prognosis, or possible risks. The medical protocol was not followed: no colposcopy was performed, no follow-up was scheduled, vaccination was not offered, and no recommendations for risk factor modification were given. This led to late detection of cancer and serious consequences for the woman’s life.
System response
Madrid authorities confirmed that the compensation payment process is in its final stage, although the insurance company has yet to provide payment confirmation. According to El Pais, more than 600 compensation claims for healthcare system errors were filed in the region in 2024, with many resolved out of court. Behind these numbers are real tragedies: loss of children during childbirth, postoperative complications, and prescription mistakes.
A medical inspection report emphasized that timely information and proper monitoring could have enabled early detection and less traumatic treatment of the disease. The insurance company also admitted that lack of oversight and prevention was a key factor in the development of the severe illness.
Context and consequences
The decision to award compensation exceeding 215,000 euros marks a significant precedent for the entire healthcare system of Madrid. It highlights the imperative to strictly adhere to medical protocols and to fully inform patients about risks and test results. According to russpain.com, such cases prompt a review of professional standards at medical institutions and an increase in staff accountability.
In recent years, Spain has seen a rise in incidents where patients experience the consequences of delayed communication or diagnostic errors. For example, similar cases have been reported in Valencia and Barcelona, where delays in relaying test results led to serious complications. These incidents generate public debate and come under discussion at the level of regional health ministries. As a result, there is greater oversight of care quality and new standards for informing patients are being implemented.
